Treatment of headaches with botulinum toxin

Expert Review of Neurotherapeutics
Julia Samton, Alexander Mauskop

Abstract

Primary headache disorders, such as migraine, chronic daily headache (CDH), and chronic tension-type headache (CTTH), are some of the most frequent disorders encountered by physicians in the outpatient setting. Chronic headache disorders cause significant morbidity and functional impairment. Despite important advances in both pharmacological and behavioral management of headache disorders, a number of patients remain treatment resistant. Botulinum toxin (BT) is emerging as a new therapeutic alternative in the preventative treatment of headaches. BT has several advantages over current prophylactic strategies, such as reduced side-effect profile and improved patient compliance. Furthermore, there have been several studies supporting the safety and tolerability of BT in the treatment of headache disorders. Although additional large-scale studies are needed to clarify clinical predictors of response as well as optimal dosing, injection sites and mechanism of action, BT has demonstrated efficacy in the treatment of migraines and CDH. The evidence for the treatment for CTTH is less compelling.

References

Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·G E BorodicK Smith
Jan 1, 1993·Ophthalmic Plastic and Reconstructive Surgery·G E BorodicR Ferrante
Feb 7, 1998·Cephalalgia : an International Journal of Headache·W PöllmannV Pfaffenrath
Aug 18, 2000·Plastic and Reconstructive Surgery·B GuyuronJ Davis
Dec 12, 2000·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·W J BinderJ M Pogoda
Nov 17, 2001·Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses·C J Kolotylo, M E Broome
Mar 20, 2002·Current Neurology and Neuroscience Reports·Richard T Johnson
Jun 5, 2002·Plastic and Reconstructive Surgery·Bahman GuyuronJanine Davis
Sep 17, 2002·Cephalalgia : an International Journal of Headache·S D Silberstein, P J Goadsby
Nov 30, 2002·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Peter Johnson
Jan 15, 2003·Neurology·Judy T ChenBrian K Alldredge
Mar 27, 2003·Headache·V A MillerA D Hershey
Dec 23, 2003·Cephalalgia : an International Journal of Headache·W G OndoH S Derman
Jun 30, 2004·Dermatologic Clinics·Andrew C Markey
Sep 21, 2004·Cephalalgia : an International Journal of Headache·S EversA Frese
Apr 20, 2005·Headache·Eric J ErossDavid W Dodick
Apr 20, 2005·Headache·Stafford ConwayJohn Rothrock
May 7, 2005·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·F ManciniC Pacchetti
Jul 16, 2005·Journal of the American Academy of Dermatology·Alastair Carruthers, Jean Carruthers
Aug 23, 2005·Journal of the American Academy of Dermatology·Timothy R CotéM Miles Braun
Nov 9, 2005·Neurology·C L ComellaUNKNOWN Dystonia Study Group

❮ Previous
Next ❯

Citations

Jan 1, 2009·Plastic and Reconstructive Surgery·Mark W ClemensE F Shaw Wilgis
Aug 6, 2009·Progress in Neurobiology·Francesca GallettiPaola Sarchielli
May 14, 2014·British Journal of Pharmacology·Roshni Ramachandran, Tony L Yaksh
May 11, 2015·Neurobiology of Disease·Roshni RamachandranTony L Yaksh
Mar 19, 2013·Annals of Plastic Surgery·Bo Young ParkTae Hui Bae
Jul 5, 2007·American Journal of Physical Medicine & Rehabilitation·Tracy DePuyMartin K Childers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.